This date has not been verified as actual or estimated.
Primary Completion
July 2015
Actual (reported)
Study Completion
July 2015
Actual (reported)
Brief Summary
Advance care planning involves thinking about choices if the patient becomes sick, and is important for everyone. It does not matter if the patients are ill or healthy. It is especially important for people who have diseases that cannot be cured. It allows people to make sure their wishes are respected if they become very sick or are dying. Thinking about these issues can be upsetting. But, for many people, it is helpful. This type of discussion can help the family learn what the patient may want but cannot tell them when these decisions need to be made
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Recruitment status
completed
Actual enrollment (reported)
57 participants
Study completion date
July 2015
Actual (reported)
Listed locations
1 countries · 1 sites
Trial Relationships
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Related Scientific Literature
Loading related publications...
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
Study Start
April 2010
Date type not reported
This date has not been verified as actual or estimated.
To assess patient uncertainty about, knowledge of, and preference for CPR.
pre and post randomization
To longitudinally follow discussions about ADs and nature of hospitalizations
6 months post-intervention
Study Arms (2)
cardiopulmonary resuscitation (CPR) video
This pilot study involves a two-arm parallel design comparing the effectiveness of a CPR video versus a CPR narrative script in advance directive (AD) completion over a 1 month time frame post intervention.
This pilot study involves a two-arm parallel design comparing the effectiveness of a CPR video versus a CPR narrative in advance directive (AD) completion over a 1 month timeframe post intervention.
Behavioral: cardiopulmonary resuscitation (CPR) narrative script and questionnaires
Interventions
(CPR) video and questionnairesBehavioral
Baseline Assessments (10 mins),Intervention:CPR video or script (5 mins) Post intervention assessments (10 mins), Longitudinal chart review follow-up (6 months)
cardiopulmonary resuscitation (CPR) video
cardiopulmonary resuscitation (CPR) narrative script and questionnairesBehavioral
Baseline Assessments (10 mins),Intervention:CPR video or script (5 mins) Post intervention assessments (10 mins), Longitudinal chart review follow-up (6 months)
Eligibility Criteria
Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population
Patients will be recruited from the MSKCC GI medical oncology group of listed study investigators, and as above, 18 years of age or older with no advance directive completed, and will be English speaking, due to the study tools being based in English.
You may qualify if:
Primary pancreatic or hepatobiliary cancer (including ampullary carcinoma)as well as gastric and/or esophageal cancers, excluding neuroendocrine histology
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Progressive disease: Locally advanced or metastatic disease with progression on at least one course of treatment (surgery, radiation, or chemotherapy), or untreated patients unfit for therapy because of comorbidities or ECOG performance status \>2, and finally, patients with ECOG performance status 2 -- patients must have discussed on at least one occasion with the treating investigator oncologist that their cancer cannot be cured
In the estimation of the treating physician investigator, life expectancy ≤ 1 year
Known to a GI medical oncology MSKCC clinic: Patients who have already established a relationship with a GI medical oncologist (who is an investigator on this protocol) after at least one new visit in the clinic (or as an in-patient), have MSKCC pathologist confirmed cancer of an above histology, and express an initial intent to be followed primarily at MSKCC
English speaking\*
Able to provide informed consent
Age greater than or equal to 18 years
Do not have an advance directive or living will \* English is the validated language in one of the study tools, and the language in which information is communicated in the narrative and video.
You may not qualify if:
Short Portable Mental Status Questionnaire (SPMSQ) score of less than "intact mental functioning" (3 or more errors). SPMSQ in appendix.
Any patient psychological state deemed by the treating physician to pose any risk of psychological harm by issues raised in a discussion of the trial, or in its testing procedures. Any subject who may become upset during any aspect or discussion of the study will be offered counseling services.
Contact the study team to confirm eligibility.
Othercollaborator
Technology, Industry, and Agriculture
Television
Data Collection
Epidemiologic Methods
Investigative Techniques
Health Care Evaluation Mechanisms
Quality of Health Care
Health Care Quality, Access, and Evaluation
Public Health
Environment and Public Health
Primary Completion
July 2015
Actual (reported)
Study Completion
July 2015
Actual (reported)
Last Updated
July 16, 2015
Record last verified: 2015-07
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.